KE3300A - Androstadine-17-carboxylic acids and their esters - Google Patents

Androstadine-17-carboxylic acids and their esters

Info

Publication number
KE3300A
KE3300A KE3300A KE330083A KE3300A KE 3300 A KE3300 A KE 3300A KE 3300 A KE3300 A KE 3300A KE 330083 A KE330083 A KE 330083A KE 3300 A KE3300 A KE 3300A
Authority
KE
Kenya
Prior art keywords
androstadine
esters
carboxylic acids
carboxylic
acids
Prior art date
Application number
KE3300A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of KE3300A publication Critical patent/KE3300A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KE3300A 1976-02-24 1983-06-23 Androstadine-17-carboxylic acids and their esters KE3300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH225376A CH628355A5 (de) 1976-02-24 1976-02-24 Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.

Publications (1)

Publication Number Publication Date
KE3300A true KE3300A (en) 1983-08-05

Family

ID=4229445

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3300A KE3300A (en) 1976-02-24 1983-06-23 Androstadine-17-carboxylic acids and their esters

Country Status (26)

Country Link
US (1) US4285937A (xx)
JP (1) JPS52102264A (xx)
AT (1) AT361141B (xx)
AU (1) AU513559B2 (xx)
BE (1) BE851725A (xx)
CA (1) CA1084483A (xx)
CH (4) CH628355A5 (xx)
CY (1) CY1198A (xx)
DD (1) DD145918A5 (xx)
DE (1) DE2707336A1 (xx)
DK (1) DK153493C (xx)
ES (5) ES456134A1 (xx)
FR (2) FR2342302A1 (xx)
GB (1) GB1578243A (xx)
HK (1) HK57483A (xx)
HU (1) HU176762B (xx)
IE (1) IE45023B1 (xx)
IL (2) IL51519A (xx)
KE (1) KE3300A (xx)
MX (1) MX9203366A (xx)
MY (1) MY8500017A (xx)
NL (1) NL7701886A (xx)
NZ (1) NZ183418A (xx)
SE (1) SE436572B (xx)
SG (1) SG37383G (xx)
ZA (1) ZA771087B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
IT7967677A0 (it) * 1978-04-05 1979-03-30 Syntex Inc Erivati dell acido 4 alogeno etiani co ad azione antinfiammatoria e procedimento per la loro preparazione
DE3024008C2 (de) * 1980-06-24 1982-04-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 17α-Hydroxy-etiocarbonsäuren
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
JPH04506066A (ja) * 1989-06-16 1992-10-22 ジ・アップジョン・カンパニー 脈管形成を抑制するためのスラミン・タイプの化合物および脈管形成抑止ステロイド類
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
IL154175A0 (en) * 2000-08-05 2003-07-31 Glaxo Group Ltd 17. beta.-carbothioate 17. alpha-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
AU2002253342B2 (en) * 2001-04-30 2007-01-04 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
ES2339351T3 (es) * 2003-06-19 2010-05-19 Nicholas S. Bodor Mejora de la actividad y/o duracion de la accion de esteroides anti-inflamatorios blandos para la aplicacion topica u otra local.
WO2004112800A1 (en) * 2003-06-19 2004-12-29 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8835410B2 (en) 2011-05-10 2014-09-16 Bodor Laboratories, Inc. Treatment of eyelid dermatitis
CN111100176A (zh) * 2019-12-20 2020-05-05 重庆华邦胜凯制药有限公司 一种化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates

Also Published As

Publication number Publication date
ES467434A1 (es) 1979-08-16
CA1084483A (en) 1980-08-26
GB1578243A (en) 1980-11-05
DK79077A (da) 1977-08-25
IL51519A0 (en) 1977-04-29
CH628356A5 (de) 1982-02-26
DE2707336A1 (de) 1977-08-25
DD145918A5 (de) 1981-01-14
ES456134A1 (es) 1978-05-01
DK153493C (da) 1988-11-28
AU513559B2 (en) 1980-12-11
BE851725A (fr) 1977-08-23
HU176762B (en) 1981-05-28
US4285937A (en) 1981-08-25
IE45023B1 (en) 1982-06-02
IL51519A (en) 1983-03-31
JPS52102264A (en) 1977-08-27
CH628355A5 (de) 1982-02-26
FR2369297B1 (xx) 1981-03-06
FR2342302A1 (fr) 1977-09-23
CH628641A5 (de) 1982-03-15
AT361141B (de) 1981-02-25
HK57483A (en) 1983-11-25
ES467430A1 (es) 1979-08-16
ATA119477A (de) 1980-07-15
FR2342302B1 (xx) 1981-01-09
IE45023L (en) 1977-08-24
MX9203366A (es) 1992-09-01
IL61512A0 (en) 1980-12-31
DK153493B (da) 1988-07-18
MY8500017A (en) 1985-12-31
ES467433A1 (es) 1979-10-16
SE436572B (sv) 1985-01-07
NL7701886A (nl) 1977-08-26
SG37383G (en) 1984-02-17
SE7701999L (sv) 1977-08-25
FR2369297A1 (fr) 1978-05-26
ES467432A1 (es) 1979-08-16
AU2257277A (en) 1978-08-31
CY1198A (en) 1983-12-31
JPS6139959B2 (xx) 1986-09-06
NZ183418A (en) 1980-02-21
CH629824A5 (de) 1982-05-14
DE2707336C2 (xx) 1988-09-01
ZA771087B (en) 1978-01-25

Similar Documents

Publication Publication Date Title
MY8500017A (en) Androstadiene-17-carboxylic acids and their esters
IL51705A (en) Acetohydroxamic acids and their preparation
GB1542938A (en) Aminophosphonous acids and processes for their preparation
GR63666B (en) Trans-hexahydro-pyrido-indole-2-alkanols,-alkanones,-alkanonitriles-alkanoic acids 8 esters
ZA773055B (en) 12-azaprostanoic acids
JPS5291814A (en) Polyfluoroalkylthioalcohol and ester * their preparation and use
IL53692A (en) 17-hydroxy-pregn-4-ene-21-carboxylic acids and the corresponding lactones and their preparation
IL54200A0 (en) The preparation of dihalogenovinylcyclopropanecarboxylic acids and their esters
GB2040287B (en) 6-alkyl-1,2-dihydro-2-oxonicotinic acids and esters
PH13826A (en) 8-halo-dibenzofuras-3-acetic acids and certain esters thereof
AU2423177A (en) Esters
AU2985577A (en) N-chloroacetyl-n-phenyl-alanine esters
AU2266077A (en) 15, 16-dioxy prostenoic acids and esters
AU510882B2 (en) Esters of naphthyl allohols
JPS5470222A (en) Nncarboxyalkaneephosphoric acids and manufacture
NZ185901A (en) 1-aziridine-carboxylic acid esters and their preparation
AU3462178A (en) Prostenoic acids and esters
IL53466A0 (en) Esters
JPS5470243A (en) Esters and manufacture
IL52868A0 (en) The preparation of esters of thiocarbamic acids
GR63657B (en) Trans-octahydro-pyrido-pyrrolo-benzazepine-3-alkanols,-alkanonitriles,-alkanoic acids and esters
AU507077B2 (en) Arykoxyalklaminobenzoil Acids and Esters
IE44932L (en) 2-arylalkanoate acids and esters.
IL50155A (en) 6,11 dihydro-11-oxodibenz oxepinalkynoic acids and esters thereof
JPS52136174A (en) Dicarboxylic acid and its ester and their preparation